| Product Code: ETC8533936 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Netherlands continues to be a key importer of CIS insulin, with top exporting countries including Belgium, Hungary, USA, Japan, and Sweden. Despite a high Herfindahl-Hirschman Index (HHI) indicating market concentration, the compound annual growth rate (CAGR) from 2020 to 2024 remained steady at 3.85%. However, there was a significant decline in growth rate from 2023 to 2024 at -42.93%, highlighting potential shifts in the market dynamics or external factors impacting the import of insulin into the Netherlands.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands CIS Insulin Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands CIS Insulin Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands CIS Insulin Market - Industry Life Cycle |
3.4 Netherlands CIS Insulin Market - Porter's Five Forces |
3.5 Netherlands CIS Insulin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Netherlands CIS Insulin Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 Netherlands CIS Insulin Market Revenues & Volume Share, By Source, 2021 & 2031F |
4 Netherlands CIS Insulin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in the Netherlands and CIS countries |
4.2.2 Growing awareness about diabetes management and treatment options |
4.2.3 Technological advancements in insulin delivery systems |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for insulin products |
4.3.2 High cost associated with insulin therapy |
4.3.3 Limited access to healthcare services in some regions |
5 Netherlands CIS Insulin Market Trends |
6 Netherlands CIS Insulin Market, By Types |
6.1 Netherlands CIS Insulin Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Netherlands CIS Insulin Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Netherlands CIS Insulin Market Revenues & Volume, By Type I Diabetes, 2021- 2031F |
6.1.4 Netherlands CIS Insulin Market Revenues & Volume, By Type II Diabetes, 2021- 2031F |
6.2 Netherlands CIS Insulin Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Netherlands CIS Insulin Market Revenues & Volume, By Rapid Acting, 2021- 2031F |
6.2.3 Netherlands CIS Insulin Market Revenues & Volume, By Long Acting, 2021- 2031F |
6.2.4 Netherlands CIS Insulin Market Revenues & Volume, By Short Acting, 2021- 2031F |
6.2.5 Netherlands CIS Insulin Market Revenues & Volume, By Intermediate Acting, 2021- 2031F |
6.2.6 Netherlands CIS Insulin Market Revenues & Volume, By Premixed, 2021- 2031F |
6.3 Netherlands CIS Insulin Market, By Source |
6.3.1 Overview and Analysis |
6.3.2 Netherlands CIS Insulin Market Revenues & Volume, By Analog, 2021- 2031F |
6.3.3 Netherlands CIS Insulin Market Revenues & Volume, By Human Recombinant, 2021- 2031F |
7 Netherlands CIS Insulin Market Import-Export Trade Statistics |
7.1 Netherlands CIS Insulin Market Export to Major Countries |
7.2 Netherlands CIS Insulin Market Imports from Major Countries |
8 Netherlands CIS Insulin Market Key Performance Indicators |
8.1 Average time to market for new insulin products |
8.2 Adoption rate of advanced insulin delivery systems |
8.3 Number of diabetes education programs conducted in the Netherlands and CIS countries |
8.4 Percentage of diabetic population using insulin therapy |
8.5 Rate of reimbursement for insulin products by healthcare systems in the region |
9 Netherlands CIS Insulin Market - Opportunity Assessment |
9.1 Netherlands CIS Insulin Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Netherlands CIS Insulin Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.3 Netherlands CIS Insulin Market Opportunity Assessment, By Source, 2021 & 2031F |
10 Netherlands CIS Insulin Market - Competitive Landscape |
10.1 Netherlands CIS Insulin Market Revenue Share, By Companies, 2024 |
10.2 Netherlands CIS Insulin Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here